Trial intelligence / Profile preview

Aricept in severe Alzheimer's disease nursing home patients

NCT00630851Phase 3Completed

Sponsor
Pfizer
Start
Oct 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of donepezil in Alzheimer's disease (AD), sponsored by Pfizer. Started Oct 2002; status: completed.

02

Drugs

donepezil
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT00630851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00630851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call